Compound Detail
CHEMBL475351
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL475351 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | AOUMXCXOJGAKLX-UHFFFAOYSA-N |
6
Targets
6
Activities
1
Assay Types
0
PK Parameters
10
Publications
0
Known Names
Molecular Properties
403.5
MW (Da)
5.00
ALogP
7
HBA
2
HBD
85.0
PSA (Ų)
0.43
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 6 meas. best 6.02
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Vascular endothelial growth factor receptor 2 CHEMBL279 | IC50 | 6.02 | 6.02 | 960.0 | 1 |
| Proto-oncogene tyrosine-protein kinase Src CHEMBL267 | IC50 | 5.68 | 5.68 | 2100.0 | 1 |
| Angiopoietin-1 receptor CHEMBL4128 | IC50 | 5.6 | 5.6 | 2500.0 | 1 |
| Insulin-like growth factor 1 receptor CHEMBL1957 | IC50 | 5.54 | 5.54 | 2900.0 | 1 |
| Epidermal growth factor receptor CHEMBL203 | IC50 | 5.29 | 5.29 | 5100.0 | 1 |
| Vascular endothelial growth factor receptor 3 CHEMBL1955 | IC50 | 5.11 | 5.11 | 7700.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Vascular endothelial growth factor receptor 2 | IC50 | = | 960.0 | nM | 6.02 | Inhibition of VEGFR2 by virtual HTS assay | 19211246 |
| Proto-oncogene tyrosine-protein kinase Src | IC50 | = | 2100.0 | nM | 5.68 | Inhibition of Src by virtual HTS assay | 19211246 |
| Angiopoietin-1 receptor | IC50 | = | 2500.0 | nM | 5.6 | Inhibition of TIE2 by virtual HTS assay | 19211246 |
| Insulin-like growth factor 1 receptor | IC50 | = | 2900.0 | nM | 5.54 | Inhibition of IGF1R by virtual HTS assay | 19211246 |
| Epidermal growth factor receptor | IC50 | = | 5100.0 | nM | 5.29 | Inhibition of EGFR by virtual HTS assay | 19211246 |
| Vascular endothelial growth factor receptor 3 | IC50 | = | 7700.0 | nM | 5.11 | Inhibition of VEGFR3 by virtual HTS assay | 19211246 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 19211246 | 10.1016/j.bmcl.2009.01.054 | Aurora kinase B | 1 |
| 19211246 | 10.1016/j.bmcl.2009.01.054 | Aurora kinase A | 1 |
| 19211246 | 10.1016/j.bmcl.2009.01.054 | Receptor tyrosine-protein kinase erbB-2 | 1 |
| 19211246 | 10.1016/j.bmcl.2009.01.054 | Insulin receptor | 1 |
| 19211246 | 10.1016/j.bmcl.2009.01.054 | Vascular endothelial growth factor receptor 3 | 1 |
| 19211246 | 10.1016/j.bmcl.2009.01.054 | Epidermal growth factor receptor | 1 |
| 19211246 | 10.1016/j.bmcl.2009.01.054 | Insulin-like growth factor 1 receptor | 1 |
| 19211246 | 10.1016/j.bmcl.2009.01.054 | Angiopoietin-1 receptor | 1 |
| 19211246 | 10.1016/j.bmcl.2009.01.054 | Proto-oncogene tyrosine-protein kinase Src | 1 |
| 19211246 | 10.1016/j.bmcl.2009.01.054 | Vascular endothelial growth factor receptor 2 | 1 |
Data from ChEMBL 36 via Core Engine